# Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

> **NCT00326183** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1800 (actual)

## Conditions studied

- Hepatitis A
- Measles
- Mumps
- Rubella
- Chickenpox

## Interventions

- **BIOLOGICAL:** VAQTA®
- **BIOLOGICAL:** ProQuad

## Key facts

- **NCT ID:** NCT00326183
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03-26
- **Primary completion:** 2008-01-15
- **Final completion:** 2008-01-15
- **Target enrollment:** 1800 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00326183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00326183, "Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00326183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*